Daniel M. Schmitt

CIK: 0001318470

Transaction Breakdown

Open Market Buys (P)1 (12.5%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (25.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACTU

ACTUATE THERAPEUTICS, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

ACTU
ACTUATE THERAPEUTICS, INC.
Oct 28, 2026
Purchase(P)
Direct
140.8K shares at avg. $0.35$50K
ACTU
ACTUATE THERAPEUTICS, INC.
Aug 14, 2026
Tax Payment(F)
Direct
120.5K shares at avg. $1.01$122K
ACTU
ACTUATE THERAPEUTICS, INC.
Aug 14, 2026
Exercise(M)
Direct
272.1K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Apr 1, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
237K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Feb 13, 2026
Tax Payment(F)
Direct
121.9K shares at avg. $4.33$528K
ACTU
ACTUATE THERAPEUTICS, INC.
Feb 13, 2026
Exercise(M)
Direct
272.1K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Apr 1, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
66.5K shares-
ACTU
ACTUATE THERAPEUTICS, INC.
Apr 1, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
204.3K shares-

		Type	Shares	Price		Ownership
Oct 28, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Purchase(P)	140,844	$0.35	$50,000	Direct
Aug 14, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Tax Payment(F)	120,521	$1.01	$121,726	Direct
Aug 14, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Exercise(M)	272,056	-	$0	Direct
Apr 1, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Employee Stock Option (right to buy)	237,000	-	-	Direct
Feb 13, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Tax Payment(F)	121,874	$4.33	$527,714	Direct
Feb 13, 2026	ACTU ACTUATE THERAPEUTICS, INC.	Exercise(M)	272,055	-	$0	Direct
Apr 1, 2025	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Employee Stock Option (right to buy)	66,503	-	-	Direct
Apr 1, 2025	ACTU ACTUATE THERAPEUTICS, INC.	Award(A) Employee Stock Option (right to buy)	204,285	-	-	Direct

1-8 of 8 transactions

About SCHMITT DANIEL M

SCHMITT DANIEL M (SEC CIK 0001318470) files insider reports with the SEC as President, CEO and Director of ACTUATE THERAPEUTICS, INC. (ACTU).

Signal8 holds 5 ownership filings by SCHMITT DANIEL M, all Form 4s, filed between Apr 2, 2025 and Oct 29, 2026. Those filings report 8 transactions, from Apr 1, 2025 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SCHMITT DANIEL M's filings is in FORT WORTH, TX.

Recent filings by SCHMITT DANIEL M

Oct 28, 2026: Open-market purchase of ACTU shares (Form 4, code P).
Aug 14, 2026: Tax withholding of ACTU shares (Form 4, code F).
Aug 14, 2026: Option exercise of ACTU shares (Form 4, code M).
Apr 1, 2026: Grant or award of ACTU derivative securities (Form 4, code A).
Feb 13, 2026: Tax withholding of ACTU shares (Form 4, code F).

Other insiders filing for ACTUATE THERAPEUTICS, INC. (ACTU)

THOMSON TODD S, Director
BIOS Fund III, LP, Director
BIOS Fund I, LP, Director
Zabrowski Dan, Director
Sawhney Roger, Director
RONNEBERG AMY L, Director

How to read Form 4 transaction codes